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Abstract
Diet has an important role in the prevention and treatment of hypertension. In early
epidemiological studies, conducted mainly in the USA, monounsaturated fatty acids
showed a deleterious association with blood pressure or no relationship at all.
However, more recent studies, conducted in Mediterranean countries, have shed new
light on this issue. In the present review we summarise the main results of
epidemiological studies and feeding trials, and explain the possible mechanisms
through which monounsaturated fatty acids, and specifically olive oil as the major
dietary source of this type of fat in Mediterranean countries, could exert a favourable
effect on blood pressure.
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Diet plays an important role in the primary prevention of
hypertension (HT)1,2. Reduction of sodium and alcohol
intake, an increase in potassium intake, and modification
of the whole dietary pattern are the best-supported
recommendations for the prevention of this disorder3,4.
Based in an increasing amount of evidence, the classical
Mediterranean dietary pattern has been proposed as a
healthy choice for the prevention of cardiovascular
disease5. Part of its beneficial impact can be mediated
through a favourable effect on blood pressure (BP)6. A
major characteristic of the Mediterranean diet is a high
supply of energy coming from monounsaturated fatty
acids (MUFA), mainly from olive oil.
Laboratory data and results from epidemiological
studies and clinical trials are accruing to support the
importance of MUFA, and more particularly of olive oil, in
the prevention of HT. In the present paper, we review the
effect of MUFA and olive oil on BP levels and their possible
role in the prevention and treatment of HT. Initially, we
describe the epidemiological evidence linking MUFA,
olive oil and BP. Then, we summarise the results of
controlled feeding studies and clinical trials. Finally, we
point out the possible physiological mechanisms through
which MUFA and olive oil can reduce BP and prevent the
development of HT.
Dietary sources of MUFA
MUFA are fatty acids with a single double bond in the
molecule. The most abundant MUFA in the diet is oleic
acid (C18:1n–9). Table 1 shows the foods with the highest
amounts of MUFA7–9. In Mediterranean countries, the
main source of MUFA in the diet is olive oil. Other
important dietary sources of MUFA are nuts and some
types of meat. In the USA and Northern Europe, meat is
one of the main sources of MUFA10,11.
Virgin (non-refined) olive oil, besides its MUFA content,
has important amounts of antioxidants and phytochem-
icals. However, when refined or heated to frying
temperature in air, olive oil loses most of these non-lipidic
natural compounds12.
Additionally, new oil variants, rich in oleic acid, have
been developed in recent decades. Thus, high-oleic-acid
sunflower, soybean, safflower, corn and peanut oils are
available on the market9. Along with the high amount of
MUFA achieved in these oil variants, another characteristic
is their increased amount of a-tocopherol.
Epidemiological evidence
Some epidemiological studies have assessed the relation-
ship between types of dietary fat and incidence of HT or
changes in BP (Table 2 6, 13–20). However, most of them
have been conducted in the USA and Northern Europe,
where overall MUFA consumption is only moderate and
comes mainly from some types of meat, and hence is
highly correlated with the intake of saturated fat. In fact,
most epidemiological studies conducted outside Mediter-
ranean countries have not found relevant associations
between MUFA intake and the risk of HT.
An ecological analysis of NHANES III data (Third
National Health and Nutritional Examination Survey)
found a higher consumption of MUFA in regions with the
highest mean BP21. Results from prospective studies show
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similar results. In nearly 60 000 US women included in the
Nurses’ Health Study, followed from 1980 to 1984, there
was no relationship between total fat, saturated fat or
unsaturated fat intake and the risk of HT13. A more recent
analysis of the same cohort reached similar conclusions14.
Similarly, the Health Professionals’ Follow-up Study,
analysing more than 30 000 US men who were followed
for 4 years, did not find any association between BP and
intake of saturated, polyunsaturated or trans-unsaturated
fat15. In the Chicago Western Electric Company Study, a
cohort with nearly 1800 men followed up over 8 years,
intakes of total fat, saturated fatty acids (SFA), polyunsa-
turated fatty acids (PUFA) and MUFA were positively and
significantly related to average annual change in systolic
BP16. Results from the Multiple Risk Factor Intervention
Trial showed an inverse association of BPwith PUFA intake
andwith the dietary PUFA/SFA ratio, but the authors did not
report any association between MUFA and BP17. Only one
small cross-sectional study conducted in 76 middle-aged
Americanmen showed an inverse relationship between BP
and MUFA intake as assessed from 3-day food records18.
All these studies adjusted their analyses for potential
confounding factors, including other dietary exposures.
Also, the prospective design in most of them precluded a
reverse causation bias; i.e. that changes in diet may be
derived from the previous knowledge of BP levels.
On the contrary, the few epidemiological studies
conducted in Southern Europe show very different results,
suggesting a protective role for MUFA or olive oil. The high
proportion that meat represents as a major source of MUFA
in Western diets may have hindered the ability of
epidemiological studies conducted in the USA and North-
ern European countries to find a protective effect of MUFA
on HT. Southern European countries, where a substantial
proportion of the population still follows the traditional
olive oil-rich Mediterranean diet, are the ideal setting to
ascertain this association, thus avoiding the strong
correlation between MUFA and meat intake. Investigators
from the Italian Nine Communities Study assessed the
relationship between olive oil consumption and BP in
almost 5000 middle-aged non-hypertensive individuals.
Results showed a statistically significant inverse associ-
ation, both for systolic and diastolic BP, and for both men
and women when analysed separately, in spite of the
moderate quality of the dietary assessment (researchers
used a qualitative food-frequency questionnaire with only
35 items)19. In this same study, PUFA were associated with
lower systolic BP but had no effect on diastolic BP.
In Greece, the cradle of the Mediterranean diet concept,
a cross-sectional analysis of 20 343 EPIC (European
Prospective Investigation into Cancer and Nutrition)
Table 1 Content of monounsaturated fatty acids (MUFA) in some
foods
MUFA (g/100g)
Oils
Olive oil 73.9
Sunflower oil 31.8
High-oleic-acid sunflower oil 83.6
Safflower oil 14.4
High-oleic-acid safflower oil 74.6
Corn oil 29.3
Soybean oil 24.3
Canola oil 58.9
Peanut oil 46.2
Foods
Peanuts 23.4
Hazelnuts 42.2
Almonds 36.6
Lard 41.6
Butter 26.8
Sources: Moreiras et al.7, US Department of Agriculture8, and Martı´nez-
Force and Garce´s9.
Table 2 Epidemiological studies assessing the relationship between monounsaturated fatty acids intake, olive oil consumption and
hypertension
Study Country Study design Participants Main results
Studies conducted in non-Mediterranean countries
Nurses’ Health Study13,14 USA Cohort 58 218 women aged 34–59 years No effect on risk of HT
Health Professionals’
Follow-up Study15
USA Cohort 30 681 men aged 40–75 years No effect on risk of HT
Chicago Western Electric
Company Study16
USA Cohort 1714 men aged 40–55 years MUFA directly associated with
increase in BP
Multiple Risk Factor
Intervention Trial17
USA Cohort 11 342 men aged 35–57 years No effect on BP
Williams et al.18 USA Cross-sectional 76 men aged 30–55 years MUFA intake inversely associated
with BP levels
Studies conducted in Mediterranean countries
Italian Nine Communities
Study19
Italy Cross-sectional 4903 men and women
aged 20–59 years
OO consumption inversely
associated with BP levels
EPIC–Greece6 Greece Cross-sectional 20 343 men and women
aged 20–86 years
OO consumption and MUFA/SFA ratio
inversely associated with BP levels
SUN Study20 Spain Cohort 6863 men and women
aged 20–80 years
OO associated with a reduced
risk of HT among men but
not among women
EPIC – European Prospective Investigation into Cancer and Nutrition; SUN – Seguimiento Universidad de Navarra; HT – hypertension; MUFA – monoun-
saturated fatty acids; BP – blood pressure; OO – olive oil; SFA – saturated fatty acids.
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participants showed that the MUFA/SFA intake ratio was
inversely associated with systolic and diastolic BP, after
adjustment for potential confounders. Similarly, olive oil
consumption was inversely associated with BP, even after
adjustment for vegetable consumption6. For each 22 g
increase in the daily consumption of olive oil, systolic and
diastolic BP were 0.8 and 0.3mmHg lower, on average,
after adjustments were made for sex, age, education, body
mass index, waist-to-hip ratio, energy intake, physical
activity and vegetable consumption.
Another study that has assessed the relationship
between MUFA, olive oil and BP is the SUN (Seguimiento
Universidad de Navarra) Study. This cohort study has been
specifically designed to assess prospectively the effect of a
Mediterranean dietary pattern on HT, diabetes, obesity
and cardiovascular disease22. In a baseline assessment of
the first 8800 participants in this cohort, MUFA intake was
associated with a lower prevalence of HT among those
individuals with low fruit and vegetable consumption,
while this effect was not apparent among those with
higher fruit and vegetable consumption23.
However, the three previous studies had a cross-
sectional design, with their problems in establishing
causal relationships. More recently, a prospective
analysis of the SUN Study showed that olive oil
consumption was inversely associated with the risk of
developing HT among men20, but no effect was
observed among women. In this study, 5573 partici-
pants free of HT at baseline were followed up for a
median of 28.5 months. Men in the highest quintile of
olive oil consumption had a 50% reduction in the risk
of incident HT compared with those in the lowest
quintile of consumption, with a statistically significant
linear trend (P ¼ 0.02). This association was indepen-
dent of other known risk factors for HT including
relevant dietary factors. Among women, there was not a
clear relationship probably due to a low number of
incident cases of HT observed in the women of this
cohort during that period. To our knowledge, this is the
only study that has prospectively assessed the
association between olive oil and the risk of HT.
Information on diet and confounding factors was
collected before the diagnosis of HT, and the analysis
was adjusted for other factors potentially associated
with the risk of HT. Its main drawback is the self-
reported diagnosis of HT, although the validation study
conducted in that population24 and the high edu-
cational level of the study participants guarantee to a
fair extent the validity of the outcome information.
Feeding trials
Since the late 1980s, several feeding trials have examined
in a controlled environment the effect of MUFA and olive
oil on BP. A summary of their main characteristics,
including the source of MUFA and their overall results, is
presented in Table 325–35. In general, these studies were
conducted in very controlled environments, with tight
monitoring of the diets to which participants were
allocated, leading to a sharp contrast between the dietary
profiles of compared groups. Additionally, none of them
was funded by the olive oil industry. Only two of them
reported that the oils they used to feed participants were
provided by oil companies30,31.
One of the earliest studies was conducted in Italy on 57
normotensive volunteers aged 30 to 50 years. These
individuals underwent a dietary intervention with a 70%
increase in energy from SFA and a corresponding decrease
in MUFA and carbohydrates. After 6 weeks, a significant
increase in systolic and average BP was observed. BP
reverted to baseline values when participants returned to
their usual diet36. However, it was not possible to separate
changes in BP derived from decreases in MUFA intake or
from other dietary changes.
In a study conducted in Spain, 42 subjects were fed two
different diets during 5-week periods. Diets differed in
their fatty acid composition, while energy intake from
carbohydrate, proteins and fat was held constant.
Compared with a diet rich in SFA (17% of total energy
intake), an olive oil-enriched diet (21% of total energy
intake from MUFA) was associated with lower levels of
mean BP30. A similar study, conducted in 41 male young
volunteers, showed that a diet rich in MUFA (22% of total
energy intake), from olive oil, had a beneficial effect on
glucose metabolism and BP compared with a diet rich in
SFA or carbohydrate31.
Similarly, Thomsen et al. observed that an olive oil-
rich diet (30% of total energy intake from MUFA)
administered during 3 weeks significantly reduced
systolic and diastolic BP compared with a PUFA-rich
diet (27% of total energy intake) in a group of 16
normotensive type 2 diabetics28. This same group
reported a beneficial effect of an olive oil-enriched diet
compared with a high-carbohydrate diet26. Another
study in 47 healthy normotensive volunteers showed a
reduction of BP after a diet with a high amount of
MUFA, from olive oil, compared with a diet rich in SFA.
However, in this case, the MUFA diet did not perform
better than a high-carbohydrate diet25. In women with
gestational diabetes, MUFA (from high-oleic sunflower
oil) intake prevented the BP increase in the third
trimester of pregnancy compared with a diet rich in
carbohydrates34.
Ferrara et al. reported that a diet rich in extra virgin olive
oil was associated with a reduced need for antihyperten-
sive medication compared with a diet enriched in
sunflower oil32. In this randomised cross-over trial, 23
hypertensive patients were assigned to each diet over
periods of 6 months. Compared with the sunflower oil
diet, the olive oil diet reduced significantly both systolic
and diastolic BP (28mmHg and26mmHg, respectively).
Daily drug dosage was significantly reduced during
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the olive oil diet but not with the sunflower oil diet
(approximately 50% vs. 4% reduction). This study suggests
that olive oil can be used as a non-pharmacological
approach in the treatment of HT.
More recently, the OmniHeart cross-over randomised
trial compared the effect of three different diets on BP, a
CHO-rich DASH (Dietary Approaches to Stop Hyperten-
sion) diet, a protein-rich diet and a MUFA-rich diet, in a
group of 164 adults older than 30 years with pre-
hypertension or stage 1 HT. After 6 weeks, the protein-
and MUFA-rich diets produced higher reductions in BP
than the CHO diet. However, there were no differences
between the MUFA- and protein-rich diets33.
It has been hypothesised that the effect of olive oil on BP
is not only mediated through its MUFA content. Other
compounds, such as the polyphenols present in virgin olive
oil, can have a favourable effect. To assess this hypothesis,
some studies have compared the effect of olive oil and
high-oleic-acid sunflower oil on BP, both with a similar
content in MUFA. Ruiz-Gutie´rrez et al. reported a reduction
in both systolic and diastolic BP after an olive oil-rich diet
but not after a high-oleic-acid sunflower oil diet29.
Not all studies have shown a beneficial effect on BP
from MUFA or olive oil intake. For example, Perona et al.
showed that a diet enriched with 60 g of virgin olive oil,
compared with 60 g of sunflower oil, daily for 4 weeks,
reduced systolic but not diastolic BP in a group of 31
hypertensives, with no effect on 31 normotensive
individuals35. In the same way, fish oil but not olive oil
was effective in the reduction of diastolic BP in a cross-
over study on 10 hypertensive subjects (9 g fish oil or 9 g
olive oil daily for 6 weeks)27. Another study conducted in
44 male mild hypertensives showed that systolic BP during
psychophysiological stress was significantly lower after a
diet enriched in sunflower oil (60ml daily for 2 weeks),
but not after olive oil or linseed oil supplementation (same
amount for the same time)37.
Canola oil is also rich in MUFA. Some animal studies
have assessed its effect on BP. In general, the results do not
show an important beneficial effect of this vegetable oil on
BP38,39. On the contrary, rats fed diets rich in canola oil
lived a shorter time than rats fed with PUFA-enriched
diets40,41. To our knowledge, the only feeding trial
conducted in human subjects did not find any significant
effect for a diet enriched with canola oil on BP compared
with a diet enriched with sunflower oil42. Similarly, with
the exception of the studies that have used high-oleic-acid
sunflower oil, there is no evidence in humans that MUFA-
rich oils other than olive oil have a favourable impact
on BP.
We can summarise this evidence as follows: although
there are some inconsistencies, MUFA from vegetable
sources, especially from olive oil in the context of
Mediterranean diets, can be beneficial in the management
of HT and probably may play a role in the primary
prevention of this disorder.
Physiological mechanisms
The mechanisms through which MUFA and olive oil could
modify BP levels are not completely clear. In the first
place, although the number of studies is scarce, it seems
that a high MUFA intake modifies membrane phospholi-
pids in a way43,44 that can, in turn, alter BP regulation and
lead to lower levels of BP29. In fact, a recent study has
shown that a molecule derived from oleic acid, 2-
hydroxyoleic acid, has an impressive antihypertensive
effect45. The authors of this study observed that the effect
could be mediated through the modification of membrane
proteins.
Results from the Pizarra Study46 have suggested another
explanation for the possible beneficial effect of MUFA on
BP. In this study, the amount of polar compounds in
cooking oil, resulting from the degradation of vegetable
oils during the cooking process, was directly associated
with BP levels. Interestingly, the utilisation of olive oil as
cooking oil reduced the formation of these polar
compounds. Moreover, olive oil consumption was directly
associated with the MUFA content of plasma phospholi-
pids. This, in turn, was inversely associated with BP levels.
Polyphenols present in olive oil, such as oleuropein,
hydroxytyrosol, tyrosol and caffeic acid, have an
important antioxidant effect. In rat leucocytes, these
molecules have been shown to inhibit leukotriene B4
generation at the 5-lipoxygenase level and to reduce the
generation of reactive oxygen species47 – these later
molecules causing endothelial dysfunction, a process that
has been implicated in the pathophysiology of HT48.
Finally, vascular response to a hypertensive stimulus was
reduced in rats fed virgin olive oil but not high-oleic-acid
sunflower oil, suggesting additional effects of olive oil
beyond its MUFA composition49. These mechanistic
findings of a beneficial effect due to the non-lipidic
fraction of olive oil fit well with the epidemiological
evidence that supports a major benefit associated not with
all MUFA, but specifically with MUFA derived from olive
oil (studies conducted in Mediterranean countries) and
even more for virgin olive oil, rich in polyphenols.
Finally, several studies have assessed the effect of a
MUFA-rich diet on endothelial function, mainly by way of
evaluating flow-mediated dilation. Results regarding the
acute postprandial effects of these diets have been
inconclusive. MUFA intake worsened flow-mediated
dilation50 in some cases, had no effect51,52 or improved
endothelial function53. Interestingly, in the only study
where MUFA had an acute adverse impact on endothelial
function, this harmful effect was cancelled out when olive
oil, as the source of MUFA, was consumed with foods
(balsamic vinegar and salad), which is the usual way of
olive oil consumption in Mediterranean countries50. More-
over, in the long term, diets rich in olive oil have shown an
improvement in endothelial function compared with a
high-carbohydrate diet54 or a high-linoleic-acid diet55.
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In conclusion, there is laboratory and epidemiological
evidence to suggest that MUFA, and particularly olive oil,
could be components of a diet with some potential to be
recommended for the prevention of HT. The results
presented here suggest that adherence by the population at
large to a Mediterranean dietary pattern, with an abundant
supply of virgin olive oil, might reduce the overall
prevalence of HT in Western societies, with important
consequences for public health nutrition. None the less,
results from prospective studies at a population level and
primary prevention trials are needed before we can firmly
recommend olive oil in the primary prevention of HT.
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